184 related articles for article (PubMed ID: 20730936)
1. Characterization of the chemotactic and mitogenic response of SMCs to PDGF-BB and FGF-2 in fibrin hydrogels.
Ucuzian AA; Brewster LP; East AT; Pang Y; Gassman AA; Greisler HP
J Biomed Mater Res A; 2010 Sep; 94(3):988-96. PubMed ID: 20730936
[TBL] [Abstract][Full Text] [Related]
2. The chemotactic and mitogenic effects of platelet-derived growth factor-BB on rat aorta smooth muscle cells are inhibited by basic fibroblast growth factor.
Facchiano A; De Marchis F; Turchetti E; Facchiano F; Guglielmi M; Denaro A; Palumbo R; Scoccianti M; Capogrossi MC
J Cell Sci; 2000 Aug; 113 ( Pt 16)():2855-63. PubMed ID: 10910770
[TBL] [Abstract][Full Text] [Related]
3. Covalently immobilized platelet-derived growth factor-BB promotes angiogenesis in biomimetic poly(ethylene glycol) hydrogels.
Saik JE; Gould DJ; Watkins EM; Dickinson ME; West JL
Acta Biomater; 2011 Jan; 7(1):133-43. PubMed ID: 20801242
[TBL] [Abstract][Full Text] [Related]
4. Platelet-derived growth factor-BB-induced human smooth muscle cell proliferation depends on basic FGF release and FGFR-1 activation.
Millette E; Rauch BH; Defawe O; Kenagy RD; Daum G; Clowes AW
Circ Res; 2005 Feb; 96(2):172-9. PubMed ID: 15625285
[TBL] [Abstract][Full Text] [Related]
5. Urokinase and tissue-type plasminogen activator are required for the mitogenic and chemotactic effects of bovine fibroblast growth factor and platelet-derived growth factor-BB for vascular smooth muscle cells.
Herbert JM; Lamarche I; Carmeliet P
J Biol Chem; 1997 Sep; 272(38):23585-91. PubMed ID: 9295297
[TBL] [Abstract][Full Text] [Related]
6. Sodium butyrate inhibits platelet-derived growth factor-induced proliferation of vascular smooth muscle cells.
Ranganna K; Joshi T; Yatsu FM
Arterioscler Thromb Vasc Biol; 1995 Dec; 15(12):2273-83. PubMed ID: 7489253
[TBL] [Abstract][Full Text] [Related]
7. Focal adhesion kinase facilitates platelet-derived growth factor-BB-stimulated ERK2 activation required for chemotaxis migration of vascular smooth muscle cells.
Hauck CR; Hsia DA; Schlaepfer DD
J Biol Chem; 2000 Dec; 275(52):41092-9. PubMed ID: 10998418
[TBL] [Abstract][Full Text] [Related]
8. Lysyl oxidase oxidizes cell membrane proteins and enhances the chemotactic response of vascular smooth muscle cells.
Lucero HA; Ravid K; Grimsby JL; Rich CB; DiCamillo SJ; Mäki JM; Myllyharju J; Kagan HM
J Biol Chem; 2008 Aug; 283(35):24103-17. PubMed ID: 18586678
[TBL] [Abstract][Full Text] [Related]
9. Differences in cellular responses to mitogens in arterial smooth muscle cells derived from patients with moyamoya disease.
Yamamoto M; Aoyagi M; Fukai N; Matsushima Y; Yamamoto K
Stroke; 1998 Jun; 29(6):1188-93. PubMed ID: 9626293
[TBL] [Abstract][Full Text] [Related]
10. Platelet-derived growth factor beta-receptors can both promote and inhibit chemotaxis in human vascular smooth muscle cells.
Clunn GF; Refson JS; Lymn JS; Hughes AD
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2622-9. PubMed ID: 9409235
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of intermediate-conductance Ca2+-activated K+ channel (IKCa1) mediates phenotypic modulation of coronary smooth muscle.
Tharp DL; Wamhoff BR; Turk JR; Bowles DK
Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2493-503. PubMed ID: 16798818
[TBL] [Abstract][Full Text] [Related]
12. Neuraminidase-1, a subunit of the cell surface elastin receptor, desialylates and functionally inactivates adjacent receptors interacting with the mitogenic growth factors PDGF-BB and IGF-2.
Hinek A; Bodnaruk TD; Bunda S; Wang Y; Liu K
Am J Pathol; 2008 Oct; 173(4):1042-56. PubMed ID: 18772331
[TBL] [Abstract][Full Text] [Related]
13. Mitogenic factors promoting intestinal smooth muscle cell proliferation.
Stanzel RD; Lourenssen S; Nair DG; Blennerhassett MG
Am J Physiol Cell Physiol; 2010 Oct; 299(4):C805-17. PubMed ID: 20631246
[TBL] [Abstract][Full Text] [Related]
14. Potentiation by platelet-derived growth factor-BB of FGF-2-stimulated VEGF release in osteoblasts.
Tokuda H; Takai S; Hanai Y; Harada A; Matsushima-Nishiwaki R; Kato H; Ogura S; Kozawa O
J Bone Miner Metab; 2008; 26(4):335-41. PubMed ID: 18600399
[TBL] [Abstract][Full Text] [Related]
15. Platelet-derived growth factor-BB and Ets-1 transcription factor negatively regulate transcription of multiple smooth muscle cell differentiation marker genes.
Dandré F; Owens GK
Am J Physiol Heart Circ Physiol; 2004 Jun; 286(6):H2042-51. PubMed ID: 14751865
[TBL] [Abstract][Full Text] [Related]
16. Heterodimerization of FGF-receptor 1 and PDGF-receptor-alpha: a novel mechanism underlying the inhibitory effect of PDGF-BB on FGF-2 in human cells.
Faraone D; Aguzzi MS; Ragone G; Russo K; Capogrossi MC; Facchiano A
Blood; 2006 Mar; 107(5):1896-902. PubMed ID: 16322476
[TBL] [Abstract][Full Text] [Related]
17. Mitogenic response of adult rat olfactory ensheathing glia to four growth factors.
Yan H; Bunge MB; Wood PM; Plant GW
Glia; 2001 Mar; 33(4):334-42. PubMed ID: 11246232
[TBL] [Abstract][Full Text] [Related]
18. Heparan sulfate proteoglycans mediate a potent inhibitory signal for migration of vascular smooth muscle cells.
Koyama N; Kinsella MG; Wight TN; Hedin U; Clowes AW
Circ Res; 1998 Aug; 83(3):305-13. PubMed ID: 9710123
[TBL] [Abstract][Full Text] [Related]
19. Thiazolidinediones prevent PDGF-BB-induced CREB depletion in pulmonary artery smooth muscle cells by preventing upregulation of casein kinase 2 alpha' catalytic subunit.
Garat CV; Crossno JT; Sullivan TM; Reusch JE; Klemm DJ
J Cardiovasc Pharmacol; 2010 May; 55(5):469-80. PubMed ID: 20147842
[TBL] [Abstract][Full Text] [Related]
20. Antiproliferative activity of NQ304, a synthetic 1,4-naphthoquinone, is mediated via the suppressions of the PI3K/Akt and ERK1/2 signaling pathways in PDGF-BB-stimulated vascular smooth muscle cells.
Kim TJ; Yun YP
Vascul Pharmacol; 2007 Jan; 46(1):43-51. PubMed ID: 16875883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
